Xgene Pharmaceutical Inc.
PrivateLast Round
Series C
Nov 4, 2021
Total Funding Raised
$60M
Company Overview
Xgene Pharmaceutical Inc. is a biotechnology company that develops innovative, multimodal conjugated small molecule drugs to treat neurological disorders and chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xgene Pharmaceutical Inc. Comparables
Compare Xgene Pharmaceutical Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Latigo Biotherapeutics | 87% | |
| Kallyope | 78% | |
| PharmNovo AB | 77% |
Xgene Pharmaceutical Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 4, 2021 | ||||
| Series B Extension | May 4, 2019 | ||||
| Series B | Oct 1, 2018 |
Xgene Pharmaceutical Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Taiwania Capital | Series B Extension |
| CITIC Securities | Series C |
| TF Capital | Series B, Series A |
| Ping An Ventures | Series C, Series B |
| Hengxu Capital | Series C |
| 5Y Capital | Series B, Series A |
| Yijing Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 4, 2021
$40M round led by CITIC Securities, Hengxu Capital, and Neovision Capital.
- May 4, 2019
Taiwania Capital participated in the round.
Xgene Pharmaceutical Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Xgene Pharmaceutical Inc.'s valuation, stock price, and market status.
Is Xgene Pharmaceutical Inc. a public or private company?
Xgene Pharmaceutical Inc. is a private company.
What is the current stock price of Xgene Pharmaceutical Inc.?
Xgene Pharmaceutical Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Xgene Pharmaceutical Inc. worth (valuation)?
Valuation information for Xgene Pharmaceutical Inc. is not publicly available.
Can I buy Xgene Pharmaceutical Inc. stock?
Xgene Pharmaceutical Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Xgene Pharmaceutical Inc.'s last funding round?
Xgene Pharmaceutical Inc.'s most recent funding round was Series C on November 4, 2021.
Who are the main investors in Xgene Pharmaceutical Inc.?
Key investors in Xgene Pharmaceutical Inc. include CITIC Securities, Ping An Ventures, Hengxu Capital, Neovision Capital.
Will Xgene Pharmaceutical Inc. IPO soon?
No public IPO plans have been announced for Xgene Pharmaceutical Inc..
How can I track Xgene Pharmaceutical Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xgene Pharmaceutical Inc.'s secondary market activity and sign up for updates.